Excitement builds as Color expands the analysis to a total of 30 genes - providing a more comprehensive hereditary cancer risk analysis!
The test now covers genes conferring risk for developing breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach and uterine cancers. Genes included on the broader panel can significantly impact an individual’s risk of these cancers. For example, an APC mutation can increase the risk of colorectal cancer in both women and men up to 70-100% by age 80.
The test cost remains the same, 399 euros. This makes the Color test not only available to everyone, but also provides unbeatable cost-effectiveness compared to any other lab.
We are proud to be working with the global leader in hereditary cancer risk analysis and will continue making genetic testing accessible!